Ashland Inc. (ASH)
| Market Cap | 3.28B +47.0% |
| Revenue (ttm) | 1.84B -1.4% |
| Net Income | 52.00M |
| EPS | 1.15 |
| Shares Out | 45.79M |
| PE Ratio | 62.25 |
| Forward PE | 17.26 |
| Dividend | $1.68 (2.35%) |
| Ex-Dividend Date | Sep 1, 2026 |
| Volume | 336,175 |
| Open | 71.25 |
| Previous Close | 71.19 |
| Day's Range | 71.25 - 72.16 |
| 52-Week Range | 47.12 - 78.25 |
| Beta | 0.40 |
| Analysts | Buy |
| Price Target | 79.91 (+11.47%) |
| Earnings Date | Nov 3, 2026 |
About ASH
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemi... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 12 analysts, the average rating for ASH stock is "Buy." The 12-month stock price target is $79.91, which is an increase of 11.47% from the latest price.
News
Ashland price target raised to $75 from $70 at Wells Fargo
Wells Fargo analyst Abigail Eberts raised the firm’s price target on Ashland (ASH) to $75 from $70 and keeps an Equal Weight rating on the shares. Ahead of earnings, the…
Ashland sales process advancing, Dealreporter says
Ashland’s (ASH) sales process is advancing with the company having collected bids last week and several private equity firms showing interest, Dealreporter said, contacts tell The Fly. Published first...
Ashland price target lowered to $80 from $83 at UBS
UBS analyst Joshua Spector lowered the firm’s price target on Ashland (ASH) to $80 from $83 and keeps a Buy rating on the shares.
Ashland announces launch of agrimer eco-disperse OD TVO polymeric dispersant
Ashland (ASH) announced the global launch of agrimer eco-disperse OD TVO polymeric dispersant, a patented, nature-based dispersant developed for non-aqueous crop protection formulations. The introduct...
Ashland scales Transformed Vegetable Oils technology platform in crop care, launches agrimer™ eco-disperse OD polymeric dispersant
WILMINGTON, Del., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Continuing to scale its Transformed Vegetable Oils (TVO™) technology platform, Ashland Inc. (NYSE: ASH), today announced the global launch of agrim...
Ashland Transcript: Investor Day 2026
Significant progress has been made in commercializing scalable, high-value technologies across core markets, validated by third-party research and strong customer engagement. The innovation pipeline targets a $9B addressable market, with multiple platforms advancing to launch and a disciplined approach to capital allocation supporting 200-300 basis points of growth above market.
Ashland Slides: FY 2026
Ashland has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 17, 2026.
Ashland collecting bids in September, Dealreporter says
Ashland (ASH), which is running a sales process, is collecting bids in September, Dealreporter said, according to trading sources. Apollo Global Management (APO) and Carlyle Group (CG) are among the…
Ashland Innovation Day to be held September 17, 2026
Wilmington, Del., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host an Innovation Day webcast on September 17, 2026.
Ashland to host Innovation Day for analysts and investors
Wilmington, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day webcast for analysts and investors from Wilmington, Delaware on September 17, 2026. The eve...
Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support...
Ashland price in low/mid-$90s ‘likely gets a deal done,’ says Wolfe Research
Wolfe Research notes Bloomberg suggests that Ashland (ASH) is pursuing a potential sale process after receiving takeover interest. Despite persistent shareholder pressures, the firm doesn’t believe As...
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock.
Ashland working with banks to explore potential sale, Bloomberg says
Ashland (ASH) is exploring a potential sale after receiving takeover interest, Ryan Gould, Liana Baker, Kiel Porter and Mengqi Sun of Bloomberg report, citing people familiar with the matter. The…
Ashland exploring sale after takeover interest, Bloomberg reports
15:57 EDT Ashland (ASH) exploring sale after takeover interest, Bloomberg reports
Ashland jumps 4% to $75.69 after Bloomberg report of takeover interest
15:57 EDT Ashland (ASH) jumps 4% to $75.69 after Bloomberg report of takeover interest
Ashland price target raised to $78 from $58 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Ashland (ASH) to $78 from $58 and keeps an Equal Weight rating on the shares. The firm said its new price target…
Ashland price target raised to $85 from $74 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Ashland (ASH) to $85 from $74 and keeps a Buy rating on the shares.
Ashland price target raised to $83 from $75 at UBS
UBS raised the firm’s price target on Ashland (ASH) to $83 from $75 and keeps a Buy rating on the shares.
Ashland price target raised to $80 from $75 at JPMorgan
JPMorgan raised the firm’s price target on Ashland (ASH) to $80 from $75 and keeps an Overweight rating on the shares.
Ashland price target raised to $73 from $60 at Evercore ISI
Evercore ISI raised the firm’s price target on Ashland (ASH) to $73 from $60 and keeps an In Line rating on the shares.
Ashland Earnings Call Transcript: Q3 2026
Third quarter sales grew 7% year-over-year, led by strong volume gains in Life Sciences and Personal Care, while operational improvements and pricing actions supported sequential profitability. Fiscal 2026 guidance was reaffirmed, with further margin recovery expected in Q4.
Ashland Earnings release: Q3 2026
Ashland released its Q3 2026 earnings on July 29, 2026, summarizing the period's financial results.
Ashland Slides: Q3 2026
Ashland has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on July 29, 2026.
Ashland Quarterly report: Q3 2026
Ashland has published its Q3 2026 quarterly earnings report on July 29, 2026.